Diabetes Mellitus Clinical Trial
Official title:
Living Hungry Healthy Foods Prescription Program
| Verified date | October 2020 |
| Source | Tufts University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study is a pre/post, pilot evaluation of the 4-month, Living Hungry program for food-insecure patients with uncontrolled diabetes. The program provides free produce, whole grains and legumes to participants and their household every-other week, in addition, to nutrition education and glucose monitoring devices. The study is analyzing diabetes management indicators, including HbA1c, dietary quality, food insecurity, and medication adherence, plus health care utilization.
| Status | Completed |
| Enrollment | 35 |
| Est. completion date | October 13, 2020 |
| Est. primary completion date | July 25, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: 1. Referred patient from one of four medical partners: My Clinic, C.L. Brumback Clinic, FoundCare and Jupiter Medical Center and has been a patient for at least one-year. 2. Diabetic with A1C over 8.0 3. Adults 18 years of age or older 4. Food-insecure Exclusion Criteria: 1. Referred patients with HbA1c levels below 8.0 mmol/mol 2. Minors 3. Adults with severe mental illness who cannot provide informed consent, unless they have present a lawful caregiver or power of attorney. 4. Anyone who does not plan on staying in West Palm Beach for the next 4 months. 5. Pregnant women (can still receive services through the program but will not be included in the analysis) |
| Country | Name | City | State |
|---|---|---|---|
| United States | Living Hungry | West Palm Beach | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| Tufts University | FoundCare Inc., Health Care District of Palm Beach County, Jupiter Medical Center, Living Hungry, Inc., MyClinic, Inc, South Florida Hunger Coalition |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in Hemoglobin A1c | will be measured by blood draws at first and last program event | pre/post change in HbA1c in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in frequency of hospitalizations | will be measured through surveys and data from electronic medical records | pre/post change in hospitalizations in participants from baseline to one month after completion of the program | |
| Secondary | Change in frequency of emergency department admissions | will be measured through surveys and data from electronic medical records | pre/post change in emergency department admissions in participants from baseline to one month after completion of the program | |
| Secondary | Change in total health care costs | will be measured through data from hospital records | pre/post change in total health care costs in participants from baseline to one month after completion of the program | |
| Secondary | Change in food insecurity | Food insecurity will be measured using the USDA 9-question food insecurity screener | pre/post change in food insecurity in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in daily servings of fruits and vegetables | Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool | pre/post change in daily servings of fruits and vegetables in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in daily servings of whole grains | Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool | pre/post change in daily servings of whole grains in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in daily servings of lean proteins | Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool and includes: nuts, seeds, legumes, poultry, and fish. | pre/post change in daily servings of lean proteins in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in daily servings of sugary snacks and drinks | Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool and includes: sugar sweetened beverages, pastries, cookies, cakes, candy, and other sweets | pre/post change in daily servings of sugary snacks and drinks in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in medication adherence | Measured as a composite score that will be assessed through a survey. Components include: frequency of sacrificing medication purchases for other household needs (such as food, utilities) and change in medication use. | pre/post change in medication adherence in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in adhering to recommended diabetes management plan | Measured as a composite scale that will be assessed through a survey. Components include frequency in which participants followed the recommendations of their physicians to manage their diabetes. | pre/post change in in adhering to recommended diabetes management in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in blood LDL level | measured at first and last program event through a blood draw | pre/post change in systolic blood LDL levels in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in systolic blood pressure | measured at first and last program event | pre/post change in systolic blood pressure in participants from baseline to completion of the program at 4 months | |
| Secondary | Change in diastolic blood pressure | measured at first and last program event | pre/post change in diastolic blood pressure in participants from baseline to completion of the program at 4 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |